Filing Details
- Accession Number:
- 0001179110-18-010052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-01 16:37:50
- Reporting Period:
- 2018-07-30
- Accepted Time:
- 2018-08-01 16:37:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1399519 | M David Weber | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2018-07-30 | 11,000 | $22.44 | 167,124 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 400 | $352.15 | 166,724 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 1,000 | $353.26 | 165,724 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 2,087 | $354.18 | 163,637 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 2,400 | $355.13 | 161,237 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 4,794 | $356.23 | 156,443 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 4,001 | $357.09 | 152,442 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 1,200 | $358.15 | 151,242 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 1,500 | $359.06 | 149,742 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 400 | $360.38 | 149,342 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 400 | $360.85 | 148,942 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 100 | $362.64 | 148,842 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 400 | $363.05 | 148,442 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 300 | $363.96 | 148,142 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 100 | $365.00 | 148,042 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-07-30 | 200 | $365.91 | 147,842 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-07-30 | 11,000 | $0.00 | 11,000 | $22.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,000 | 2013-05-22 | 2022-05-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $.01 Par Value | 15,497 | Indirect | By Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 23,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 10,000 | Direct |
| Common Stock | Stock Option (right to buy) | $99.62 | 2017-05-24 | 2026-05-24 | 0 | 7,000 | Direct |
| Common Stock | Stock Option (right to buy) | $134.51 | 2018-05-15 | 2027-05-15 | 0 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $381.97 | 2019-05-16 | 2028-05-16 | 0 | 6,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-05-14 | 0 | 23,000 | Direct |
| 2024-05-14 | 0 | 15,000 | Direct |
| 2025-05-13 | 0 | 10,000 | Direct |
| 2026-05-24 | 0 | 7,000 | Direct |
| 2027-05-15 | 0 | 8,000 | Direct |
| 2028-05-16 | 0 | 6,500 | Direct |
Footnotes
- This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $351.6600 and $352.5100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $352.7300 and $353.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $353.7800 and $354.5300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $354.7400 and $355.6300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $355.7500 and $356.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $356.6700 and $357.5900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $357.6800 and $358.5200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $358.6900 and $359.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $359.7300 and $360.6400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $360.7200 and $361.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $362.7500 and $363.500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $363.7200 and $364.3100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
